Asklepios Kliniken · ISIN: DE000A0ETLQ3 · EQS - Company News

Consistent growth in first nine months of 2024

Asklepios Group: Consistent growth in first nine months of 2024 Consolidated revenue totals EUR 4,350.8 million Patient numbers up 6% at 2.7 million Refinancing as part of Social SSD issue Hamburg, 28 November 2024. Asklepios Kliniken GmbH & Co. KGaA has generated stable growth over the first nine months of 2024. In a volatile macro-economic and healthcare policy environment, Asklepios has managed to increase its treatment numbers once more and to achieve positive consolidated earnings. T...
About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Asklepios Kliniken

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
28 November 2024 10:00AM
Consistent growth in first nine months of 2024
DE000A0ETLQ3
Asklepios Group: Consistent growth in first nine months of 2024 Consolidated revenue totals EUR 4,350.8 million Patient numbers up 6% at 2.7 million Refinancing as part of Social SSD issue Hamburg, 28 November 2024. Asklepios Kliniken GmbH & Co. KGaA has generated stable growth over the first nine months of 2024. In a volatile macro-economic...
Asklepios Kliniken
About the publication
06 November 2024 10:00AM
Asklepios places its first Social Schuldschein loan of EUR 500.0 million
DE000A0ETLQ3
Asklepios places its first Social Schuldschein loan of EUR 500.0 million First transaction under the newly established Social Finance Framework Issuance proceeds to be used for (re-)financing social projects High demand for the Social Schuldschein loan enabled a doubling of the issuance volume Hamburg, November 6, 2024. Asklepios Kliniken GmbH &...
Asklepios Kliniken
About the publication
29 August 2024 10:00AM
Positive development continued in the first half of 2024 - solid basis for further strategic development
DE000A0ETLQ3
Asklepios Group: Positive development continued in the first half of 2024 - solid basis for further strategic development Consolidated revenue of EUR 2,902.6 million above previous year's level Consolidated interim income EAT has improved at EUR 74.1 million Consolidated position as leading hospital operator in Germany Hamburg, 29 August 2024. A...
Asklepios Kliniken
About the publication
23 May 2024 10:00AM
Positive business performance in first quarter – Confident outlook for 2024
DE000A0ETLQ3
Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024 Consolidated revenue up year-on-year at EUR 1,414.5 million Consolidated net income (EAT) of EUR 18.5 million Increase in patient and employee numbers Hamburg, 23 May 2024. Asklepios Kliniken GmbH & Co. KGaA has enjoyed a solid economic performance i...
Asklepios Kliniken
About the publication
25 April 2024 10:00AM
Asklepios shows resilience in 2023 financial year
DE000A0ETLQ3
Asklepios Group: Asklepios shows resilience in 2023 financial year Revenue at EUR 5,452.3 million Number of patients treated rises 2.4% to 3.5 million Number of FTEs grows thanks to effective strategies to counter the shortage of qualified staff Hamburg, 25 April 2024. Despite the challenges arising from persistent inflation and structural uncer...
Asklepios Kliniken
About the publication
23 November 2023 10:00AM
Sound business performance in first nine months of 2023
DE000A0ETLQ3
Asklepios Group: Sound business performance in first nine months of 2023 Revenue improves to EUR 4,077.7 million Inflation-driven price increases and higher staff costs affect consolidated net income Syndicated loan increased by EUR 200.0 million Hamburg, 23 November 2023. Asklepios Kliniken GmbH & Co. KGaA recorded sound business performanc...
Asklepios Kliniken
About the publication
24 August 2023 10:00AM
Stable development in H1 2023 despite challenging market environment
DE000A0ETLQ3
Asklepios Group: Stable development in H1 2023 despite challenging market environment Consolidated revenue up slightly year-on-year at EUR 2,708.4 million Asklepios increases investments from own funds Real price increases and higher staff costs negatively impact earnings Hamburg, 24 August 2023. Asklepios Kliniken GmbH & Co. KGaA recorded s...
Asklepios Kliniken
About the publication
25 May 2023 10:00AM
DE000A0ETLQ3
Asklepios Group: Resilient business performance in Q1 2023 More than 850,000 patients cared for Consolidated revenue amounts to EUR 1,341.8 million Asklepios invests EUR 47.4 million of own funds Hamburg, 25 May 2023. Asklepios Kliniken GmbH & Co. KGaA has made a resilient start to the first quarter of 2023. As such, Asklepios has establishe...
Asklepios Kliniken
About the publication
25 May 2023 10:00AM
Asklepios Kliniken:
DE000A0ETLQ3
Asklepios Group: Resilient business performance in Q1 2023 More than 850,000 patients cared for Consolidated revenue amounts to EUR 1,341.8 million Asklepios invests EUR 47.4 million of own funds Hamburg, 25 May 2023. Asklepios Kliniken GmbH & Co. KGaA has made a resilient start to the first quarter of 2023. As such, Asklepios has establishe...
Asklepios Kliniken
About the publication
28 April 2023 11:00AM
Solid performance in 2022
DE000A0ETLQ3
Asklepios Group: Solid performance in 2022 Hamburg, 28 April 2023. 2022 was a challenging financial year for Asklepios Kliniken GmbH & Co. KGaA that was dominated by global political and economic developments. The Asklepios Group’s healthcare facilities treated around 3.6 million patients in the 2022 financial year, a slight increase on the p...
Asklepios Kliniken
About the publication
28 April 2023 11:00AM
Asklepios Kliniken: Solid performance in 2022
DE000A0ETLQ3
Asklepios Group: Solid performance in 2022 Hamburg, 28 April 2023. 2022 was a challenging financial year for Asklepios Kliniken GmbH & Co. KGaA that was dominated by global political and economic developments. The Asklepios Group’s healthcare facilities treated around 3.6 million patients in the 2022 financial year, a slight increase on the p...
Asklepios Kliniken
About the publication
02 March 2023 10:00AM
Asklepios Kliniken: Group-wide ESG strategy
DE000A0ETLQ3
Asklepios Kliniken: Group-wide ESG strategy Hamburg, 2 March 2023. Asklepios Kliniken GmbH & Co. KGaA has adopted a Group-wide ESG strategy on the basis of successful groundwork. In addition to environmental issues, the strategy also covers social and governance aspects, which are equally important for a healthcare group. As a large healthca...
Asklepios Kliniken
About the publication
02 March 2023 10:00AM
Group-wide ESG strategy
DE000A0ETLQ3
Asklepios Kliniken: Group-wide ESG strategy Hamburg, 2 March 2023. Asklepios Kliniken GmbH & Co. KGaA has adopted a Group-wide ESG strategy on the basis of successful groundwork. In addition to environmental issues, the strategy also covers social and governance aspects, which are equally important for a healthcare group. As a large healthca...
Asklepios Kliniken
About the publication
21 December 2022 05:00PM
Asklepios Kliniken: Asklepios signs off on first-ever commercial paper program for EUR 500 million
DE000A0ETLQ3
Asklepios signs off on first-ever commercial paper program for EUR 500 million Opening up new sources of debt capital Strategic expansion of existing financing instruments Hamburg, 21 December 2022. Asklepios Kliniken GmbH & Co. KGaA has signed off on the company's first-ever commercial paper (CP) program for EUR 500 million, thus gaining ac...
Asklepios Kliniken
About the publication
21 December 2022 05:00PM
Asklepios signs off on first-ever commercial paper program for EUR 500 million
DE000A0ETLQ3
Asklepios signs off on first-ever commercial paper program for EUR 500 million Opening up new sources of debt capital Strategic expansion of existing financing instruments Hamburg, 21 December 2022. Asklepios Kliniken GmbH & Co. KGaA has signed off on the company's first-ever commercial paper (CP) program for EUR 500 million, thus gaining ac...
Asklepios Kliniken
About the publication
24 November 2022 10:00AM
Sound business performance in first nine months of 2022
DE000A0ETLQ3
Asklepios Group: Sound business performance in first nine months of 2022 Consolidated revenue amounts to EUR 3,935.4 million Over 2.65 million patients treated Hamburg, 24 November 2022. Asklepios Kliniken GmbH & Co. KGaA has posted a stable business performance in the first nine months of 2022. Over the coming months, the general economic si...
Asklepios Kliniken
About the publication
24 November 2022 10:00AM
Asklepios Kliniken: Sound business performance in first nine months of 2022
DE000A0ETLQ3
Asklepios Group: Sound business performance in first nine months of 2022 Consolidated revenue amounts to EUR 3,935.4 million Over 2.65 million patients treated Hamburg, 24 November 2022. Asklepios Kliniken GmbH & Co. KGaA has posted a stable business performance in the first nine months of 2022. Over the coming months, the general economic si...
Asklepios Kliniken
About the publication
25 August 2022 10:00AM
Asklepios Kliniken: Stable development continues in H1 2022
DE000A0ETLQ3
Asklepios Kliniken: Stable development continues in H1 2022 Consolidated revenue amounts to EUR 2,608.9 million. Energy prices and inflation pose new challenges for hospital market Hamburg, 25 August 2022. Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated n...
Asklepios Kliniken
About the publication
25 August 2022 10:00AM
Stable development continues in H1 2022
DE000A0ETLQ3
Asklepios Kliniken: Stable development continues in H1 2022 Consolidated revenue amounts to EUR 2,608.9 million. Energy prices and inflation pose new challenges for hospital market Hamburg, 25 August 2022. Asklepios Kliniken GmbH & Co. KGaA has closed the first half of 2022 with a stable development of consolidated revenue and consolidated n...
Asklepios Kliniken
About the publication
25 May 2022 10:00AM
Asklepios Kliniken: Sound growth despite challenging environment in first quarter of 2022
DE000A0ETLQ3
Asklepios Group: Sound growth despite challenging environment in first quarter of 2022 Number of patients up 15.6% Consolidated revenue of EUR 1,276.3 million Well equipped for current uncertainties with central, standardized purchasing strategy Hamburg, 25 May 2022. In a first quarter dominated by the war in Ukraine and the continuing effects o...
Asklepios Kliniken
About the publication
28 April 2022 10:00AM
Asklepios Kliniken: Stable development in 2021 financial year despite negative impact from COVID-19 pandemic
DE000A0ETLQ3
Asklepios Kliniken: Stable development in 2021 financial year despite negative impact from COVID-19 pandemic Consolidated net income (EAT) of EUR 106.3 million Number of patients treated comes to around 3.5 million Consistently high capital expenditure of EUR 332.6 million, own funds ratio of 72.8% Strategic partnership with Rhön-Klinikum AG ha...
Asklepios Kliniken
About the publication
25 November 2021 09:00AM
Asklepios Kliniken: Stable business performance in the first nine months of 2021
DE000A0ETLQ3
Asklepios Kliniken: Stable business performance in the first nine months of 2021 About 2.4 million patients being treated Consolidated revenue of EUR 3,818.8 million Sharp rise in COVID-19 patients expected in hospitals Hamburg, 25 November 2021. The business development of Asklepios Kliniken GmbH & Co. KGaA gradually stabilised in the first...
Asklepios Kliniken
About the publication
08 November 2021 06:00PM
Asklepios Kliniken: Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer
DE000A0ETLQ3
Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer Successful extension of maturity profile through early refinancing of schuldschein maturities in 2022 and 2023 Significant interest from existing investors Hamburg, 8 November 2021. Asklepios Kliniken GmbH & Co. KGaA has achieved early refinan...
Asklepios Kliniken
About the publication
26 August 2021 09:00AM
Asklepios Kliniken: Coronavirus pandemic still having an impact in H1 2021
DE000A0ETLQ3
Asklepios Kliniken: Coronavirus pandemic still having an impact in H1 2021 Consolidated revenue of EUR 2,526.4 million Consolidated net income (EAT) of EUR 43.0 million Capacity utilisation stabilised at 1,447,999 patients in total Sustainable investment policy focused on digitalisation Hamburg, 26 August 2021. Asklepios Kliniken GmbH & Co....
Asklepios Kliniken
About the publication
27 May 2021 10:00AM
Asklepios Kliniken: COVID-19 pandemic impacting first quarter of 2021
DE000A0ETLQ3
Asklepios Kliniken: COVID-19 pandemic impacting first quarter of 2021 Consolidated revenue of EUR 1,221.0 million Compensation payments not sufficient to cover decline in treatments Rehabilitation clinics and psychiatric hospitals currently without reliable aid Continuation of sustainable investment policy underpinned by solid internal financin...
Asklepios Kliniken
About the publication
29 April 2021 10:00AM
Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition
DE000A0ETLQ3
Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition Consolidated net loss of EUR -65.1 million Significant increase in material and staff costs Revenue losses and cost increases outweigh government support Security of care always ensured at all locations Hamburg, 29 April 2021. The year 2020 brought enormous...
Asklepios Kliniken
About the publication
26 November 2020 06:00PM
Asklepios Kliniken: Consolidated net operating income impacted by continuing coronavirus pandemic
DE000A0ETLQ3
Asklepios Group: Consolidated net operating income impacted by continuing coronavirus pandemic Patient numbers down by around 30% Net operating income impacted by effects of coronavirus Hamburg, 26 November 2020. In July 2020, Asklepios Kliniken GmbH & Co. KGaA completed the acquisition of RHÖN-KLINIKUM AG. As of the end of the third quarter ...
Asklepios Kliniken
About the publication
28 October 2020 05:55PM
Asklepios successfully issues Schuldschein loan agreement worth EUR 730 million
DE000A0ETLQ3
Asklepios successfully issues Schuldschein loan agreement worth EUR 730 million Multiple oversubscription: original issue volume of EUR 200 million increased to EUR 730 million Continued strong interest from national and international investors in the megatrend of health Hamburg, 28 October 2020. Asklepios Kliniken GmbH & Co. KGaA has success...
Asklepios Kliniken
About the publication
27 August 2020 09:04AM
Asklepios Kliniken posts sound development in operating business in first half of 2020 despite coronavirus
DE000A0ETLQ3
Asklepios Kliniken posts sound development in operating business in first half of 2020 despite coronavirus Consolidated revenue of EUR 1,809.6 million Consolidated net income (EAT) falls to EUR 21.8 million Number of patients declines by 11.7% to 1,084,287 due to coronavirus pandemic Acquisition of RHÖN-KLINIKUM AG successfully completed Hambur...
Asklepios Kliniken
About the publication
More Asklepios Kliniken related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN